Schizoaffective Disorders Precision Medicine - Heterogeneity in Schizophrenia
Johns Hopkins Medicine via YouTube
Overview
Syllabus
Intro
The challenge: Heterogeneity in schizophrenia
Approaches to schizophrenia heterogeneity Heterogeneity based on clinical phenotype
Heterogeneity based on treatment response (Hypothesis developed at Hopkins by Fred Nucifora)
Challenges for TRS and UTRS patients
The Johns Hopkins approach to clinical heterogeneity of various diseases: PMCOEs supported by inHealth
Limitations of Precision Psychiatry
Meaning of "schizoaffective" in our PMCOE
PMCOE Organization
Guiding Hypotheses of the PMCOE
PMCOE Levels of analysis
Clinical Component of PMCOE
Johns Hopkins Schizophrenia Patient Populations
Clinical Assessment Protocol
Clinical Questions to be addressed
Mining the EMR for clinical insight
Circuitry Projects
Thalamo-cortical connectivity abnormalities in scz/scz-aff detected with 7T MRI
Challenges of thalamocortical imaging
Solving the problem of cortical layers
Hua group: vascular imaging
Circuitry as probed electrophysiologically (EEG)
Cell pathology: protein aggregation
Insoluble protein detected in -1/3 of post- mortem scz post-mortem brains
Detecting insoluble protein in cells
Extracellular vesicles (Evs): An alternative approach to exploring pathogenic markers in patient cells
Extracellular vesicles: Detection in blood by Gerber Lab
Approach to CUL1: cell and mouse models
ANK3: a gene linked to mood disorder
Schizoaffective Disorder PMCOE Projects
Taught by
Johns Hopkins Medicine